Authors: Bertoni, F de Tomasi, D Vitali, E De Agostini, A Baroncelli, G Cafaro, I D'Affronto, C Richetti, A Valli, M Palazzi, M Meregalli, S Asnaghi, D Arienti, V Cavallini, D Pradella, R Di Lorenzo, I

Citation: F. Bertoni et al., Radiotherapy for early breast cancer in elderly women: A subgroup analysisfrom a multicenter, observational, prospective study on 1610 patients, TUMORI, 87(4), 2001, pp. S139-S139

Authors: Riccardi, A Tinelli, C Brugnatelli, S Pugliese, P Giardina, V Giordano, M Danova, M Richetti, A Fava, S Rinaldi, E Fregoni, V Trotti, G Poli, A

Citation: A. Riccardi et al., Doubling of the epirubicin dosage within the 5-fluorouracil, epirubicin and cyclophosphamide regimen: a prospective, randomized, multicentric study on antitumor effect and quality of life in advanced breast cancer, INT J ONCOL, 16(4), 2000, pp. 769-776

Authors: Spriano, G Antognoni, P Sanguineti, G Sormani, M Richetti, A Ameli, F Piantanida, R Luraghi, R Magli, A Corvo, R Tordiglione, M Vitale, V

Citation: G. Spriano et al., Laryngeal long-term morbidity after supraglottic laryngectomy and postoperative radiation therapy, AM J OTOLAR, 21(1), 2000, pp. 14-21

Authors: Amichetti, M Caffo, O Richetti, A Zini, G Rigon, A Antonello, M Roncadin, M Coghetto, F Valdagni, R Fasan, S Maluta, S Di Marco, A Neri, S Vidali, C Panizzoni, G Aristei, C

Citation: M. Amichetti et al., Subclinical ductal carcinoma in situ of the breast: Treatment with conservative surgery and radiotherapy, TUMORI, 85(6), 1999, pp. 488-493

Authors: Begg, AC Haustermans, K Hart, AAM Dische, S Saunders, M Zackrisson, B Gustaffson, H Coucke, P Paschoud, N Hoyer, M Overgaard, J Antognoni, P Richetti, A Bourhis, J Bartelink, H Horiot, JC Corvo, R Giaretti, W Awwad, H Shouman, T Jouffroy, T Maciorowski, Z Dobrowsky, W Struikmans, H Rutgers, D Wilson, GD

Citation: Ac. Begg et al., The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis, RADIOTH ONC, 50(1), 1999, pp. 13-23

Authors: Riccardi, A Brugnatelli, S Giordano, M Danova, M Pugliese, P Tinelli, C Klersy, C Richetti, A Fava, S Nastasi, G Rinaldi, E Fregoni, V De Monte, A Trotti, G Bovio, A Ascari, E

Citation: A. Riccardi et al., Myeloprotective effect of early primary granulocyte-colony stimulating factor during six courses of intensified 5-fluorouracil, epirubicin and cyclophosphamide (120FEC) chemotherapy for advanced breast cancer, TUMORI, 84(5), 1998, pp. 540-546